On 2023-11-08, SQZ Biotechnologies Company (SQZB) announced earnings per share of $-0.54 for the fiscal quarter ending 2023-09-30, beating the average analyst estimate of $-0.66.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-11-08 | 2023-09-30 | $-0.66 | $-0.54 |
| 2023-08-10 | 2023-06-30 | $-0.60 | $-0.57 |
| 2023-05-10 | 2023-03-31 | $-0.54 | $-0.60 |
| 2023-03-22 | 2022-12-31 | $-0.80 | $-0.46 |
| 2022-11-09 | 2022-09-30 | $-0.89 | $-0.77 |
| 2022-08-04 | 2022-06-30 | $-0.79 | $-0.78 |
| 2022-05-10 | 2022-03-31 | $-0.71 | $-0.75 |
| 2022-03-16 | 2021-12-31 | $-0.67 | $-0.41 |
| 2021-11-10 | 2021-09-30 | $-0.55 | $-0.80 |
| 2021-08-04 | 2021-06-30 | $-0.57 | $-0.68 |
| 2021-05-11 | 2021-03-31 | $-0.73 | $-0.59 |
| 2020-12-10 | 2020-09-30 | $-3.64 | $-7.03 |